These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 11881131

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
    Karlberg BE, Lins LE, Hermansson K.
    J Hypertens; 1999 Feb; 17(2):293-302. PubMed ID: 10067800
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension.
    Nalbantgil I, Nalbantgil S, Ozerkan F, Yilmaz H, Gürgün C, Zoghi M, Aytimur M, Onder R.
    Int J Clin Pract Suppl; 2004 Dec; (145):50-4. PubMed ID: 15617460
    [Abstract] [Full Text] [Related]

  • 6. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG, Dahlöf B, Sechtem U, Unger T, Knecht M, Dietz R, TELMAR Investigators.
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical efficacy and safety of telmisartan 80 mg once daily compared with enalapril 20 mg once daily in patients with mild-to-moderate hypertension: results of a multicentre study.
    Alcocer L, Fernandez-Bonetti P, Campos E, Dominguez-Henkel R, de la Fuente JJ, Segovia-Ayala C.
    Int J Clin Pract Suppl; 2004 Dec; (145):23-8. PubMed ID: 15617455
    [Abstract] [Full Text] [Related]

  • 10. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM, Kolloch RE, Plouin PF, Meinicke TW, Schumacher H, OTELLOH Study Group.
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A double-blind comparison of the efficacy and tolerability of telmisartan 40-80 mg vs. losartan 50-100 mg in Taiwanese hypertensive patients.
    Lee YT, Lee CM, Lin CS, Sheu SH, Kuo WK, Tsai CW, Huang LC, Huang HC, Wang JS, Tseng WK.
    Int J Clin Pract Suppl; 2004 Dec; (145):40-5. PubMed ID: 15617458
    [Abstract] [Full Text] [Related]

  • 16. Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension.
    McGill JB, Reilly PA.
    Clin Cardiol; 2001 Jan; 24(1):66-72. PubMed ID: 11195609
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators.
    Dunselman PH, Replacement of Angiotensin Converting Enzyme Inhibition (REPLACE) Investigators.
    Int J Cardiol; 2001 Feb; 77(2-3):131-8; discussion 139-40. PubMed ID: 11182175
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.